Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies
Cells · 2025
DOI: 10.3390/cells14231874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Hao Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases …. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Regulated Cell Death. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Collaboration Project of Traditional Chinese and Western Medicine in the Major Difficult Diseases in Hubei Province, Leading talents of public health in Hubei Province.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease defined by persistent airflow limitation, chronic inflammation, and ongoing airway remodeling, and poses a substantial global health challenge. Despite its clinical significance, the underlying cellular mechanisms remain poorly defined. Regulated cell death (RCD) incorporates various kinds of cell death that are typically regulated by specific molecular pathways. Numerous new kinds of RCD have been identified outside of the traditional apoptotic pathway, like necroptosis, pyroptosis, ferroptosis, autophagy, cuproptosis, and parthanatos. To date, there is growing evidence indicating that these pathways participate in the regulation of COPD development. However, their specific roles and therapeutic relevance remain poorly understood. In this review, we discuss a summary of the molecular mechanisms by which RCD pathways influence the onset and advancement of COPD. Additionally, the therapeutic benefits of agents that target these cell death pathways in COPD treatment were described. By integrating current insights, this review aims to broaden our knowledge of the pathophysiology of COPD and offer novel approaches to treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong…
Förderung
- National Natural Science Foundation of China
- Clinical Collaboration Project of Traditional Chinese and Western Medicine in the Major Difficult Diseases in Hubei Province
- Leading talents of public health in Hubei Province
- Project of Key R&D Program in Hubei Province
- Major Project of National Science and Technology
Zitieren
APA
Fu, H., Huang, Q., & Xie, J. (2025). Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies. Cells. https://doi.org/10.3390/cells14231874
Vancouver
Fu H, Huang Q, Xie J. Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies. Cells. 2025. doi:10.3390/cells14231874
BibTeX
@article{Fu2025,
author = {Fu, Hao and Huang, Qian and Xie, Jungang},
title = {Targeting Regulated Cell Death Pathways in COPD: Mechanisms and Therapeutic Strategies},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14231874}
}
EUVIMED